¼¼°èÀÇ ÆóȰ·®°è ½ÃÀå
Spirometers
»óǰÄÚµå : 1761078
¸®¼­Ä¡»ç : Global Industry Analysts, Inc.
¹ßÇàÀÏ : 2025³â 07¿ù
ÆäÀÌÁö Á¤º¸ : ¿µ¹® 179 Pages
 ¶óÀ̼±½º & °¡°Ý (ºÎ°¡¼¼ º°µµ)
US $ 5,850 £Ü 8,068,000
PDF (Single User License) help
PDF º¸°í¼­¸¦ 1¸í¸¸ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.
US $ 17,550 £Ü 24,204,000
PDF (Global License to Company and its Fully-owned Subsidiaries) help
PDF º¸°í¼­¸¦ µ¿ÀÏ ±â¾÷ÀÇ ¸ðµç ºÐÀÌ ÀÌ¿ëÇÒ ¼ö ÀÖ´Â ¶óÀ̼±½ºÀÔ´Ï´Ù. Àμâ´Â °¡´ÉÇϸç Àμ⹰ÀÇ ÀÌ¿ë ¹üÀ§´Â PDF ÀÌ¿ë ¹üÀ§¿Í µ¿ÀÏÇÕ´Ï´Ù.


Çѱ۸ñÂ÷

ÆóȰ·®°è ¼¼°è ½ÃÀåÀº 2030³â±îÁö 22¾ï ´Þ·¯¿¡ ´ÞÇÒ Àü¸Á

2024³â¿¡ 13¾ï ´Þ·¯·Î ÃßÁ¤µÇ´Â ÆóȰ·®°è ¼¼°è ½ÃÀåÀº 2024³âºÎÅÍ 2030³â±îÁö CAGR 8.8%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 22¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÀÌ º¸°í¼­¿¡¼­ ºÐ¼®ÇÑ ºÎ¹® Áß ÇϳªÀÎ Å×À̺íÅéÀº CAGR 8.5%¸¦ ±â·ÏÇÏ¸ç ºÐ¼® ±â°£ Á¾·á±îÁö 10¾ï ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ÇÚµåÇïµå ºÎ¹®ÀÇ ¼ºÀå·üÀº ºÐ¼® ±â°£ µ¿¾È CAGR 7.2%·Î ÃßÁ¤µË´Ï´Ù.

¹Ì±¹ ½ÃÀåÀº 3¾ï 7,120¸¸ ´Þ·¯·Î ÃßÁ¤, Áß±¹Àº CAGR 8.2%·Î ¼ºÀå ¿¹Ãø

¹Ì±¹ÀÇ ÆóȰ·®°è ½ÃÀåÀº 2024³â¿¡ 3¾ï 7,120¸¸ ´Þ·¯·Î ÃßÁ¤µË´Ï´Ù. ¼¼°è 2À§ °æÁ¦ ´ë±¹ÀÎ Áß±¹Àº 2024³âºÎÅÍ 2030³â ºÐ¼® ±â°£ µ¿¾È CAGR 8.2%·Î ¼ºÀåÇÏ¿© 2030³â¿¡´Â 3¾ï 4,260¸¸ ´Þ·¯ÀÇ ½ÃÀå ±Ô¸ð¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù. ±âŸ ÁÖ¸ñÇÒ ¸¸ÇÑ Áö¿ªº° ½ÃÀåÀ¸·Î´Â ÀϺ»°ú ij³ª´Ù°¡ ÀÖ°í, ºÐ¼® ±â°£ µ¿¾È CAGRÀº °¢°¢ 7.8%¿Í 7.7%·Î ¿¹ÃøµË´Ï´Ù. À¯·´¿¡¼­´Â µ¶ÀÏÀÌ CAGR ¾à 7.0%·Î ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹ÃøµË´Ï´Ù.

¼¼°èÀÇ ÆóȰ·®°è ½ÃÀå - ÁÖ¿ä µ¿Çâ°ú ÃËÁø¿äÀÎ Á¤¸®

ÇコÄÉ¾î ºÐ¾ß¿¡¼­ ÆóȰ·®°è¿¡ ´ëÇÑ ¼ö¿ä°¡ Áõ°¡ÇÏ´Â ÀÌÀ¯´Â ¹«¾ùÀΰ¡?

ÆóȰ·®°è´Â Æó ±â´É Æò°¡ ¹× õ½Ä, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD), Æó¼¶À¯Áõ°ú °°Àº È£Èí±âÁúȯÀÇ Áø´Ü¿¡ »ç¿ëµÇ´Â ÇコÄɾîÀÇ Çʼö Áø´Ü µµ±¸ÀÔ´Ï´Ù. ´ë±â¿À¿°, Èí¿¬, °í·ÉÈ­ µîÀÇ ¿äÀÎÀ¸·Î ÀÎÇØ Àü ¼¼°èÀûÀ¸·Î È£Èí±âÁúȯÀÇ ¹ß»ý·üÀÌ Áõ°¡ÇÔ¿¡ µû¶ó, ÆóȰ·®°èÀÇ ¼ö¿ä°¡ Å©°Ô Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ ±â±â´Â ÆóȰ·®, ±â·ù ¹× ±âŸ Áß¿äÇÑ ¸Å°³ º¯¼ö¸¦ ÃøÁ¤Çϱâ À§ÇØ º´¿ø, Áø·á¼Ò, ÀÏÂ÷ Áø·á ȯ°æ, ÀçÅà °£È£¿¡¼­ ³Î¸® »ç¿ëµÇ°í ÀÖ½À´Ï´Ù. Á¶±â Áø´Ü, ¿¹¹æ ÀÇ·á, ¸ÂÃãÇü Ä¡·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁü¿¡ µû¶ó, ÆóȰ·®°è´Â ÀÇ·á Àü¹®°¡¿¡°Ô ȯÀÚÀÇ È£Èí±â °Ç°­ »óÅ¿¡ ´ëÇÑ ±ÍÁßÇÑ ÀλçÀÌÆ®¸¦ Á¦°øÇÏ¿© ¸¸¼º È£Èí±âÁúȯÀ» °ü¸®ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù.

±â¼ú Çõ½ÅÀº ÆóȰ·®°è ½ÃÀåÀ» ¾î¶»°Ô º¯È­½Ã۰í Àִ°¡?

µðÁöÅÐ, ÈÞ´ëÇü, ½º¸¶Æ®Æù ¿¬°áÇü µî ´Ù¾çÇÑ ±â¼ú ¹ßÀüÀ¸·Î ÀÎÇØ ÀÇ·áÁø°ú ȯÀÚ ¸ðµÎ¿¡°Ô ´õ ³ôÀº Á¤È®µµ, ÆíÀǼº, »ç¿ë ÆíÀǼºÀ» Á¦°øÇÏ´Â µî ÆóȰ·®°è ½ÃÀåÀÌ º¯È­Çϰí ÀÖ½À´Ï´Ù. µ¥ÀÌÅÍ ºÐ¼® ±â´ÉÀÌ °­È­µÈ ÷´Ü AI ±â¹Ý ÆóȰ·®°èÀÇ ÃâÇöÀ¸·Î È£Èí±âÁúȯÀ» º¸´Ù Á¤È®ÇÏ°Ô Áø´Ü, ¸ð´ÏÅ͸µ ¹× °ü¸®ÇÒ ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. »ç¿ëÀÚ Ä£È­ÀûÀÌ°í ºñħ½ÀÀûÀÎ ºñħ½ÀÀû ¹«¼± ÆóȰ·®°è ¼Ö·ç¼ÇÀÇ Çõ½ÅÀº ÀçÅÃ, ¿ø°Ý, ÇöÀå Áø·á ȯ°æ¿¡¼­ÀÇ Àû¿ëÀ» È®´ëÇÏ¿© ¿ø°ÝÀÇ·á ¹× ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ ÀÌ´Ï¼ÅÆ¼ºê¸¦ Áö¿øÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ÆóȰ·®°è µ¥ÀÌÅ͸¦ ÀüÀÚ ÀÇ·á ±â·Ï(EHR), Ŭ¶ó¿ìµå ±â¹Ý Ç÷§Æû ¹× µðÁöÅÐ °Ç°­ ¾ÖÇø®ÄÉÀ̼ǰú ÅëÇÕÇÏ¿© ÀÇ·á Àü¹®°¡°¡ ȯÀÚÀÇ °Ç°­ »óŸ¦ Á¾ÇÕÀûÀ¸·Î ÆÄ¾ÇÇÒ ¼ö ÀÖ°ÔÇÔÀ¸·Î½á ´õ ³ªÀº ÀÓ»óÀû ÀÇ»ç°áÁ¤À» ³»¸®°í ȯÀÚ °á°ú¸¦ °³¼±ÇÒ ¼ö ÀÖµµ·Ï µ½°í ÀÖ½À´Ï´Ù. °³¼±Çϰí ÀÖ½À´Ï´Ù.

¾î¶² ½ÃÀå ¼¼ºÐÈ­°¡ ÆóȰ·®°è »ê¾÷ÀÇ ¼ºÀåÀ» ÁÖµµÇϰí Àִ°¡?

Á¦Ç° À¯Çü¿¡´Â ÇÚµåÇïµåÇü ½ºÇǷιÌÅÍ, Ź»óÇü ½ºÇǷιÌÅÍ, µ¥½ºÅ©ÅéÇü ½ºÇǷιÌÅͰ¡ ÀÖÀ¸¸ç, ÇÚµåÇïµåÇü ½ºÇǷιÌÅÍ´Â È޴뼺, »ç¿ë ÆíÀǼº, Ȩº£À̽º ¹× ÇöÀå °Ë»ç¿¡ ÀûÇÕÇÏ¿© ½ÃÀå Á¡À¯À²ÀÌ °¡Àå ³ô½À´Ï´Ù. ±â¼ú ºÎ¹®Àº À¯·® ÃøÁ¤¿ë ÆóȰ·®°è, üÀû ÃøÁ¤¿ë ÆóȰ·®°è, ÇÇÅ© À¯·®°è·Î ±¸¼ºµÇ¸ç, À¯·® ÃøÁ¤¿ë ÆóȰ·®°è´Â Æó ±â´É ÆÄ¶ó¹ÌÅÍÀÇ ÃøÁ¤ Á¤È®µµ°¡ ³ô±â ¶§¹®¿¡ ÁÖ¿ä ºÎ¹®ÀÔ´Ï´Ù. ÆóȰ·®°è´Â õ½Ä °ü¸®, COPD °ü¸®, Æó ÀçȰ, »ê¾÷º¸°Ç¿¡ »ç¿ëµÇ¸ç, COPD °ü¸®´Â ³ôÀº À¯º´·ü°ú Á¤±âÀûÀÎ ¸ð´ÏÅ͸µÀÇ Çʿ伺À¸·Î ÀÎÇØ ÁÖ¿ä ºÎ¹®À¸·Î ²ÅÈ÷°í ÀÖ½À´Ï´Ù. ÃÖÁ¾ »ç¿ë ºÐ¾ß¿¡´Â º´¿ø, Ŭ¸®´Ð, ÀçÅÃÀÇ·á, ¿¬±¸±â°üÀÌ Æ÷ÇԵǸç, º´¿øÀº ÷´Ü Áø´Ü Àåºñ¿Í ¼÷·ÃµÈ ÀÇ·á Àü¹®°¡ÀÇ °¡¿ë¼ºÀ» ¹ÙÅÁÀ¸·Î ½ÃÀåÀ» ÁÖµµÇϰí ÀÖ½À´Ï´Ù. Áö¸®ÀûÀ¸·Î ºÏ¹Ì¿Í À¯·´Àº ³ôÀº ÀÇ·áºñ ÁöÃâ, ³ôÀº ÀÎ½Ä ¼öÁØ, ³ôÀº ¼öÁØÀÇ ÀÎÇÁ¶ó·Î ÀÎÇØ ÆóȰ·®°èÀÇ °¡Àå Å« ½ÃÀåÀ¸·Î ¼ºÀåÇϰí ÀÖ½À´Ï´Ù. ¾Æ½Ã¾ÆÅÂÆò¾çÀº ÇコÄɾî ÅõÀÚ Áõ°¡¿Í È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡·Î ÀÎÇØ ºü¸¥ ¼ºÀåÀÌ ¿¹»óµË´Ï´Ù.

ÆóȰ·®°è ½ÃÀåÀÇ ¼ºÀå ÃËÁø¿äÀÎÀº?

ÆóȰ·®°è ½ÃÀåÀÇ ¼ºÀåÀº È£Èí±âÁúȯÀÇ À¯º´·ü Áõ°¡, µðÁöÅÐ, ÈÞ´ë¿ë, ½º¸¶Æ®Æù ¿¬°áÇü ÆóȰ·®°èÀÇ ±â¼ú ¹ßÀü, ¸¸¼ºÆó¼â¼ºÆóÁúȯ(COPD)ÀÇ Á¶±â Áø´Ü ¹× ¸ð´ÏÅ͸µ¿¡ ´ëÇÑ °ü½É Áõ°¡ µî ¿©·¯ °¡Áö ¿äÀο¡ ±âÀÎÇϰí ÀÖ½À´Ï´Ù. ´Ù¾çÇÑ È£Èí±âÁúȯ¿¡ ´ëÇØ Á¤È®ÇÏ°í ½Å·ÚÇÒ ¼ö ÀÖ´Â ºñħ½ÀÀû Æó±â´É °Ë»ç¸¦ Á¦°øÇØ¾ß ÇÒ Çʿ伺ÀÌ ¿©·¯ ÀÇ·á ȯ°æ¿¡¼­ ÆóȰ·®°è ¼ö¿ä¸¦ ÃËÁøÇϰí ÀÖÀ¸¸ç, AI ±â¹Ý ÆóȰ·®°è, Ŭ¶ó¿ìµå ÅëÇÕ, EHR ȣȯ¼º, ¿ø°Ý ȯÀÚ ¸ð´ÏÅ͸µ, µ¥ÀÌÅÍ ºÐ¼®, ¼¾¼­ ±â¼ú, µðÁöÅÐ °Ç°­ °ü¸®, µ¥ÀÌÅÍ ºÐ¼®, µðÁöÅÐ °Ç°­ °ü¸® µî ´Ù¾çÇÑ ±â¼ú Çõ½ÅÀ¸·Î ÀÎÇØ µ¥ÀÌÅÍ ºÐ¼®, ¼¾¼­ ±â¼ú, µðÁöÅÐ Çコ Ç÷§ÆûÀÇ ¹ßÀü°ú ÇÔ²² ÆóȰ·®°èÀÇ ±â´É, Á¢±Ù¼º, ½ÃÀ强À» Çâ»ó½ÃÄÑ ½ÃÀå ¼ºÀåÀ» Áö¿øÇϰí ÀÖ½À´Ï´Ù. õ½Ä °ü¸®, Æó ÀçȰ, ÀÓ»ó½ÃÇè, »ê¾÷ º¸°Ç, ÀçÅÃÀÇ·á, ¿ø°ÝÀÇ·á, ¸ÂÃãÇü ÀÇ·á¿¡ ´ëÇÑ °ü½ÉÀÌ ³ô¾ÆÁö¸é¼­ ½ÃÀå Âü¿©Àڵ鿡°Ô »õ·Î¿î ±âȸ¸¦ âÃâÇϰí ÀÖ½À´Ï´Ù. ¶ÇÇÑ, ´Ù¾çÇÑ ÇコÄɾî ȯ°æÀ» À§ÇÑ »ç¿ëÀÚ Ä£È­ÀûÀÎ ¹«¼± ¹× AI Áö¿ø ÆóȰ·®°è ¼Ö·ç¼Ç °³¹ß¿¡ ÁýÁßÇÏ´Â °ÍÀº ÆóȰ·®°è ½ÃÀåÀÇ ¼ºÀåÀ» ´õ¿í ÃËÁøÇϰí ÀÖ½À´Ï´Ù.

ºÎ¹®

À¯Çü(Å×À̺íÅé, ÇÚµåÇïµå, µ¥½ºÅ©Åé), ±â¼ú(¿ëÀû ÃøÁ¤, ÃÖ´ëÈ£±â·®ÃøÁ¤±â(PFM), À¯·® ÃøÁ¤), ¿ëµµ(COPD, õ½Ä, Æó¼¶À¯Áõ, ³¶Æ÷¼º¼¶À¯Áõ, ±âŸ ¿ëµµ)

Á¶»ç ´ë»ó ±â¾÷ »ç·Ê(ÃÑ 11°³»ç)

AI ÅëÇÕ

Global Industry Analysts´Â °ËÁõµÈ Àü¹®°¡ ÄÁÅÙÃ÷¿Í AI ÅøÀ» ÅëÇØ ½ÃÀå Á¤º¸¿Í °æÀï Á¤º¸¸¦ Çõ½ÅÇϰí ÀÖ½À´Ï´Ù.

Global Industry Analysts´Â LLM ¹× ¾÷°è °íÀ¯ÀÇ SLMÀ» Á¶È¸ÇÏ´Â ÀϹÝÀûÀÎ ±Ô¹ü¿¡ µû¸£´Â ´ë½Å ºñµð¿À ±â·Ï, ºí·Î±×, °Ë»ö ¿£Áø Á¶»ç, ¹æ´ëÇÑ ¾çÀÇ ±â¾÷, Á¦Ç°/¼­ºñ½º, ½ÃÀå µ¥ÀÌÅÍ µî ¼¼°è µµ¸ÞÀÎ Àü¹®°¡°¡ ¼±º°ÇÑ ÄÁÅÙÃ÷ ¸®Æ÷ÁöÅ丮¸¦ ±¸ÃàÇß½À´Ï´Ù.

°ü¼¼ ¿µÇâ °è¼ö

Global Industry Analysts´Â º»»çÀÇ ±¹°¡, Á¦Á¶°ÅÁ¡, ¼öÃâÀÔ(¿ÏÁ¦Ç° ¹× OEM)À» ±â¹ÝÀ¸·Î ±â¾÷ÀÇ °æÀï·Â º¯È­¸¦ ¿¹ÃøÇϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ º¹ÀâÇÏ°í ´Ù¸éÀûÀÎ ½ÃÀå ¿ªÇÐÀº ¸ÅÃâ¿ø°¡(COGS) Áõ°¡, ¼öÀͼº °¨¼Ò, °ø±Þ¸Á ÀçÆí µî ¹Ì½ÃÀû ¹× °Å½ÃÀû ½ÃÀå ¿ªÇÐ Áß¿¡¼­µµ ƯÈ÷ °æÀï»çµé¿¡°Ô ¿µÇâÀ» ¹ÌÄ¥ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¹æ¹ý

Á¦2Àå ÁÖ¿ä ¿ä¾à

Á¦3Àå ½ÃÀå ºÐ¼®

Á¦4Àå °æÀï

ksm
¿µ¹® ¸ñÂ÷

¿µ¹®¸ñÂ÷

Global Spirometers Market to Reach US$2.2 Billion by 2030

The global market for Spirometers estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.2 Billion by 2030, growing at a CAGR of 8.8% over the analysis period 2024-2030. Tabletop, one of the segments analyzed in the report, is expected to record a 8.5% CAGR and reach US$1.0 Billion by the end of the analysis period. Growth in the Handheld segment is estimated at 7.2% CAGR over the analysis period.

The U.S. Market is Estimated at US$371.2 Million While China is Forecast to Grow at 8.2% CAGR

The Spirometers market in the U.S. is estimated at US$371.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$342.6 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 7.8% and 7.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 7.0% CAGR.

Global Spirometers Market - Key Trends and Drivers Summarized

Why Is the Demand for Spirometers on the Rise in Healthcare?

Spirometers are essential diagnostic tools in healthcare, used to assess lung function and diagnose respiratory conditions such as asthma, chronic obstructive pulmonary disease (COPD), and pulmonary fibrosis. With the rising incidence of respiratory diseases worldwide, driven by factors such as air pollution, smoking, and an aging population, the demand for spirometers is growing significantly. These devices are widely used in hospitals, clinics, primary care settings, and home-based care to measure lung capacity, airflow, and other critical parameters. As the focus on early diagnosis, preventive care, and personalized treatment intensifies, the adoption of spirometers is expanding, providing healthcare professionals with valuable insights into patient respiratory health and aiding in the management of chronic respiratory disorders.

How Are Technological Innovations Transforming the Spirometer Market?

Technological advancements in digital, portable, and smartphone-connected spirometers are transforming the spirometer market, offering greater accuracy, convenience, and ease of use for both healthcare providers and patients. The emergence of advanced, AI-powered spirometers with enhanced data analytics capabilities is enabling more precise diagnosis, monitoring, and management of respiratory conditions. Innovations in user-friendly, non-invasive, and wireless spirometer solutions are expanding their application in home-based, remote, and point-of-care settings, supporting telemedicine and remote patient monitoring initiatives. Additionally, the integration of spirometry data with electronic health records (EHRs), cloud-based platforms, and digital health applications is providing healthcare professionals with a comprehensive view of patient health, facilitating better clinical decision-making, and improving patient outcomes.

Which Market Segments Are Leading the Growth of the Spirometer Industry?

Product types include hand-held spirometers, table-top spirometers, and desktop spirometers, with hand-held spirometers holding a large market share due to their portability, ease of use, and suitability for home-based and point-of-care testing. Technology segments comprise flow measurement spirometers, volume measurement spirometers, and peak flow meters, with flow measurement spirometers being a key segment due to their accuracy in measuring lung function parameters. Applications of spirometers span asthma management, COPD management, pulmonary rehabilitation, and occupational health, with COPD management being the leading segment due to the high prevalence of the disease and the need for regular monitoring. End-use sectors include hospitals, clinics, home healthcare, and research institutes, with hospitals leading the market due to the availability of advanced diagnostic facilities and skilled healthcare professionals. Geographically, North America and Europe are the largest markets for spirometers, driven by high healthcare spending, awareness levels, and advanced infrastructure, while Asia-Pacific is expected to witness rapid growth due to increasing healthcare investments and rising prevalence of respiratory diseases.

What Are the Key Drivers of Growth in the Spirometer Market?

The growth in the spirometer market is driven by several factors, including rising incidence of respiratory diseases, technological advancements in digital, portable, and smartphone-connected spirometers, and the increasing focus on early diagnosis and monitoring of chronic obstructive pulmonary disease (COPD). The need to provide accurate, reliable, and non-invasive lung function testing for various respiratory conditions is driving the demand for spirometers across multiple healthcare settings. Technological innovations in AI-powered spirometers, cloud integration, EHR compatibility, and remote patient monitoring, coupled with advancements in data analytics, sensor technology, and digital health platforms, are enhancing the capabilities, accessibility, and marketability of spirometers, supporting market growth. The expansion of spirometer applications in asthma management, pulmonary rehabilitation, clinical trials, and occupational health, along with the growing emphasis on home-based care, telemedicine, and personalized medicine, is creating new opportunities for market players. Additionally, the focus on developing user-friendly, wireless, and AI-enabled spirometer solutions for diverse healthcare environments is further propelling the growth of the spirometer market.

SCOPE OF STUDY:

The report analyzes the Spirometers market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Tabletop, Handheld, Desktop); Technology (Volume Measurement, Peak Flow Meter (PFM), Flow Measurement); Application (COPD, Asthma, Pulmonary Fibrosis, Cystic Fibrosis, Other Applications)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 11 Featured) -

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

III. MARKET ANALYSIS

IV. COMPETITION

(ÁÖ)±Û·Î¹úÀÎÆ÷¸ÞÀÌ¼Ç 02-2025-2992 kr-info@giikorea.co.kr
¨Ï Copyright Global Information, Inc. All rights reserved.
PC¹öÀü º¸±â